ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

July 29, 1988

Cooperative Groups Pursue Contracts With Insurers, NCI Warns of Competition

June 14, 1996

US Sues St. Luc Hospital For Grant Funds, Expenses Of Data Reanalysis, Investigation

June 9, 1995

HIPAA Interpretations Vary, Delay Research, ASCO Study Finds

July 31, 2009

ACS Initiates New Colorectal Cancer Screening Campaign

November 18, 1983

Concepts Approved For Developmental Therapeutics Program

June 19, 1987